Clinical trialNCT04598919Active, not recruitingPhase 1/PHASE2Interventional

Saracatinib in the Treatment of Idiopathic Pulmonary Fibrosis

SponsorNational Jewish HealthEnrollment49Idiopathic Pulmonary Fibrosis (IPF)

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Annetine Gelijns, PhD
Data and Clinical Coordinating Center- InCHOIR
Principal Investigator
clinicaltrials.gov ↗
Danielle Antin-Ozerkis, MD
Yale University
Principal Investigator
clinicaltrials.gov ↗
Gregory Downey, MD
National Jewish Health
Principal Investigator
clinicaltrials.gov ↗
Maria Padilla, MD
Icahn School of Medicine at Mount Sinai
Principal InvestigatorKOL profile →
clinicaltrials.gov ↗
Susan Mathai, MD
Baylor University Medical Center (BUMC)
Principal Investigator
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States

National Jewish Health
Denver, Colorado, United States
Yale University School of Medicine
New Haven, Connecticut, United States
Icahn School of Medicine at Mount Sinai
New York, New York, United States
Baylor University Medical Center (bumc)
Dallas, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 12 Nov 2020
Primary completion: 15 Sept 2024
Completion: 30 Jun 2025
Last update posted: 14 Nov 2024
Registered enrollment: 49
Registry id: NCT04598919

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.